Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Continue Reading

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

Continue Reading

CING studies ABT with the help of VarSome Clinical

Continue Reading

Building the best in variant classification

Continue Reading

Saphetor SA receives IVDR Certification for clinical diagnosis support NGS data analysis platform, VarSome Clinical, ensuring enhanced safety and performance standards

Continue Reading

Benchmarking Variant Calling Tools - Wong et al., 2025

Continue Reading

Saphetor and Platomics announce agreement to support labs with IVDR compliance

Continue Reading

Company News listing page

By

Categories

Stay up to date

Topic: Oncology

Interpreting genomic variants is one of the most time-consuming and complex tasks in clinical genomics. Each variant must be assessed for its clinical significance using established guidelines (where available), curated databases, and the latest...

VarSome Clinical Oncology Germline

Automated Germline and Somatic Classification
By Jason Armstrong on September 22, 2025
0
Continue Reading

VarSome Clinical is a CE IVDR-certified, HIPAA-compliant platform for interpreting NGS data. It supports analysis of genomes, exomes, and gene panels from individual samples, trios, families, or cohorts.

VarSome Clinical Oncology Germline

Germline and Somatic Pipelines
By Jason Armstrong on September 22, 2025
0
Continue Reading

VarSome Clinical offers two types of filtering: algorithmic filters, which run during analysis to prioritize variants, and dynamic filters, which give you flexible control over how results are viewed and explored.Together, they help reduce noise...

VarSome Clinical Oncology Germline

Algorithmic and Dynamic Filters
By Jason Armstrong on September 22, 2025
0
Continue Reading

Tumor mutational burden (TMB) and Microsatellite Instability (MSI) are now established biomarkers guiding immunotherapy decisions across a growing list of solid tumors. This article outlines how TMB and MSI are defined and assessed in VarSome...

Platform Updates Technology VarSome Clinical Oncology

TMB & MSI Biomarkers
By Jason Armstrong on August 12, 2025
0
Continue Reading

Genomics and the Future of Maternal and Newborn Health: Closing Gaps, Saving Lives

Community VarSome.com News Awareness Days Oncology

World Health Day 2025 - Genomics in Maternal & Newborn Health
By Jason Armstrong on April 7, 2025
1
Continue Reading

Submit a Comment

Stay up to date